937PD - A phase II trial of combination nivolumab and bevacizumab in recurrent ovarian cancer
| Autor: | Liu, J.F., Herold, C., Luo, W., Penson, R., Horowitz, N., Konstantinopoulos, P., Castro, C., Curtis, J., Matulonis, U.A., Cannistra, S., Dizon, D.S. |
|---|---|
| Zdroj: | In Annals of Oncology October 2018 29 Supplement 8 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|